Sofie Arnetorp

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study

Rachael A Evans, Sabada Dube, Yi Lu et al. · The Lancet Regional Health - Europe · 2023 · 197 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program

Chloë I. Bloom, Claudia Cabrera, Sofie Arnetorp et al. · Advances in Therapy · 2020 · 121 citations · Full text

Pharmacy, Internal Medicine, Clinical Pharmacology +16

Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America

Jennifer K Quint, Sofie Arnetorp, Janwillem Kocks et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 79 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β₂-agonist use in asthma

Claudia Cabrera, Cassandra Nan, N Lindarck et al. · European Respiratory Journal · 2019 · 64 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK

J. Mark FitzGerald, Sofie Arnetorp, Caitlin Smare et al. · Respiratory Medicine · 2020 · 22 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15